Despite significant policy advancement and scientific breakthroughs, much work remains to be done to truly transform cancer care. The number of oncology clinical trials in Europe has decreased by 22% over the past 5 years; it takes on average 559 days for Europeans to access new cancer medicines; and cancer diagnoses continue to rise as the population grows and ages, placing pressure on already overextended healthcare budgets and resources.

We want to maintain the political momentum created in the last five years and avoid slipping further behind in oncology innovation. As the new EU political mandate begins, there is a collective responsibility to build on the promise of the Europe’s Beating Cancer Plan (EBCP) and the EU Mission on Cancer to leave no stone unturned to take action against cancer.

Join us on 19 March in Brussels to discuss how we can work together to accelerate progress to improve cancer care, and build a future where everyone has the best possible chance. The event will also mark the launch of the updated IHE Cancer Comparator Report, offering an overview of the current state of cancer care in Europe.

Register here.